Futura Medical (FUM) RNS Announcements

Add to Alert list
Date Time Source Announcement
20 Dec 2024 07:58 AM
RNS
Holding(s) in Company
02 Dec 2024 07:00 AM
RNS
Block Listing Six Monthly Return
15 Nov 2024 07:00 AM
RNS
TR-1: Notification of major holdings
04 Nov 2024 07:00 AM
RNS
Encouraging New Product Development Pipeline
31 Oct 2024 07:00 AM
RNS
Total Voting Rights
17 Oct 2024 02:00 PM
RNS
Clinical trial data presented at SMSNA
07 Oct 2024 07:00 AM
RNS
Further milestone payment triggered post US launch
01 Oct 2024 07:00 AM
RNS
Total Voting Rights
13 Sep 2024 07:00 AM
RNS
Directors’ / PDMR Dealing
11 Sep 2024 05:43 PM
RNS
Trinity Delta research note & consensus forecasts
10 Sep 2024 07:00 AM
RNS
Futura Medical - Interim Results 2024
02 Sep 2024 10:47 AM
RNS
Update on US Launch
02 Sep 2024 07:00 AM
RNS
Update on US launch
19 Aug 2024 07:00 AM
RNS
Notice of Results
01 Aug 2024 07:05 AM
RNS
Update on US launch
01 Jul 2024 02:13 PM
RNS
Total Voting Rights
01 Jul 2024 07:00 AM
RNS
Nominated Adviser and Joint Broker
20 Jun 2024 04:12 PM
RNS
Result of AGM
20 Jun 2024 07:00 AM
RNS
AGM Statement
31 May 2024 07:00 AM
RNS
Block Listing Six Monthly Review
24 May 2024 07:00 AM
RNS
Notice of AGM and availability of Annual Report
29 Apr 2024 07:00 AM
RNS
Directors’ / PDMR Dealing and Grant of Options
10 Apr 2024 07:00 AM
RNS
Results for the Year ended 31 December 2023
25 Mar 2024 07:00 AM
RNS
Notice of Results and Investor Presentation
14 Feb 2024 07:00 AM
RNS
Eroxon to be available on prescription
06 Feb 2024 07:01 AM
RNS
Trading Update
06 Feb 2024 07:00 AM
RNS
Appointment of Joint Corporate Broker
17 Jan 2024 07:00 AM
RNS
Director/PDMR Dealing
17 Jan 2024 07:00 AM
RNS
Remuneration of Non-Exec Directors & Voting Rights
15 Jan 2024 07:00 AM
RNS
Futura Medical extends collaboration with Cooper
09 Jan 2024 07:00 AM
RNS
Appointment of Roy Davis as Non-Executive Director
30 Nov 2023 03:10 PM
RNS
Total Voting Rights
30 Nov 2023 03:10 PM
RNS
Block Listing Six Monthly Return
07 Nov 2023 07:00 AM
RNS
Futura expands partnership with M8 Pharmaceuticals
02 Nov 2023 03:34 PM
RNS
Eroxon Awarded “New Product of the Year” by Boots
31 Oct 2023 07:00 AM
RNS
Block Listing Application and Total Voting Rights
25 Oct 2023 07:00 AM
RNS
Eroxon® Granted Marketing Authorisation in Mexico
19 Oct 2023 07:00 AM
RNS
Eroxon Launches in the United Arab Emirates
10 Oct 2023 07:00 AM
RNS
Directors’/PDMR Dealing and Grant of Options
02 Oct 2023 07:00 AM
RNS
European Patent Granted for MED3000 until 2040
18 Sep 2023 07:00 AM
RNS
Futura Medical - Interim Results 2023
18 Aug 2023 07:00 AM
RNS
Futura Medical - Notice of Interim Results
09 Aug 2023 07:00 AM
RNS
MED3000 Commercialisation Approval in Saudi Arabia
31 Jul 2023 07:00 AM
RNS
Futura Medical - Total Voting Rights
18 Jul 2023 11:04 AM
RNS
Board Change
17 Jul 2023 07:00 AM
RNS
Futura/Haleon Enter US Commercialisation Agreement
30 Jun 2023 07:00 AM
RNS
Futura Medical - Total Voting Rights
23 Jun 2023 04:30 PM
RNS
Recording of Investor Seminar
22 Jun 2023 03:19 PM
RNS
Futura Medical Annual General Meeting Results
22 Jun 2023 07:00 AM
RNS
Futura Medical AGM Statement

Futura Medical is the developer of innovative sexual health products, including lead product Eroxon®. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

FUM share price listed on AIM in 2003.

UK 100

Latest directors dealings